The Mediterranean diet has long been lauded as the gold standard for heart-healthy eating among experts. But a similar and ...

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...

Please provide your email address to receive an email when new articles are posted on . Inclisiran is now FDA approved as monotherapy for LDL reduction. The drug is no longer required to be used on ...

The body requires proper management of blood cholesterol and fats, because they serve essential health functions. The three essential blood components which people need to understand are HDL ...

LYON, France — Lerodalcibep, a novel, third-generation anti–proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, helps high-risk patients already receiving maximally tolerated statins to ...